CD164 Protein (CD164) (AA 24-162) (Fc Tag)

N° du produit ABIN7274215

Détail du produit

Antigène: CD164

Type de proteíne: Recombinant

Attributs du protein: AA 24-162

Origine: Souris

Source: HEK-293 Cells

Purification/Conjugué: Cette CD164 protéine est marqué à la Fc Tag.

Fonction: Mouse CD164 Protein

Séquence: Gln24-Asp162

Attributs du produit: Recombinant Mouse CD164 Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Gln24-Asp162.

Pureté: > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC

Stérilité: 0.22 μm filtered

niveau d'endotoxine: Less than 1EU per μg by the LAL method.

Information d'application

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.

Buffer: Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: -20 to -80°C for 12 months as supplied from date of receipt.,-80°C for 3-6 months after reconstitution.,2-8°C for 2-7 days after reconstitution.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

Date de péremption: 12 months

Détail du antigène

Antigène: CD164

Autre désignation: CD164 (CD164 Produits)

Synonymes: MGC-24 Protein, MUC-24 Protein, endolyn Protein, CD164 Protein, MGC-24v Protein, fb75f06 Protein, fj87f10 Protein, wu:fb75f06 Protein, wu:fj87f10 Protein, si:ch211-51a19.2 Protein, A115 Protein, A24 Protein, AA589639 Protein, AW540279 Protein, MSSP Protein, CD164 molecule Protein, CD164 molecule, sialomucin Protein, CD164 antigen Protein, CD164 Protein, Cd164 Protein, cd164 Protein

Sujet: CD164 was found to play a role in many malignant diseases. CD164 was associated with clinical and pathological features of patients. High level of CD164 was related to the distant metastasis and vascular invasion of bladder cancer patients.CD164 was associated with the poor clinical outcomes of BC patients. Silencing of CD164 could inhibit the progression of tumors in vivo and in vitro, which may become an effective target in the treatment of bladder cancer.

Poids moléculaire: 41.4 kDa. Due to glycosylation, the protein migrates to 70-115 kDa based on Tris-Bis PAGE result.

UniProt: Q9R0L9